Eagle Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $45.2M | Sell |
|
|||||
|
2024
Q2 | $63.6M | Buy |
|
|||||
|
2024
Q1 | $27.4M | Sell |
|
|||||
|
2023
Q4 | $20.8M | Sell |
|
|||||
|
2023
Q3 | $26.5M | Buy |
|
|||||
|
2023
Q2 | $25M | Sell |
|
|||||
|
2023
Q1 | $30.5M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $53.9M | Sell |
|
|||||
|
2020
Q3 | $48.3M | Sell |
|
|||||
|
2020
Q2 | $71.9M | Buy |
|
|||||
|
2020
Q1 | $43.1M | Sell |
|
|||||
|
2019
Q4 | $57.2M | Buy |
|
|||||
|
2019
Q3 | $32.8M | Sell |
|
|||||
|
2019
Q2 | $110M | Sell |
|
|||||
|
2019
Q1 | $109M | Sell |
|
|||||
|
2018
Q4 | $119M | Buy |
|
|||||
|
2018
Q3 | $172M | Buy |
|
|||||
|
2018
Q2 | $91M | Sell |
|
|||||
|
2018
Q1 | $72.6M | Sell |
|
|||||
|
2017
Q4 | $55.2M | Sell |
|
|||||
|
2017
Q3 | $49.9M | Buy |
|
|||||
|
2017
Q2 | $26.9M | Buy |
|
|||||
|
2017
Q1 | $17.7M | Buy |
|
|||||
|
2016
Q4 | $16.2M | Sell |
|
|||||
|
2016
Q3 | $36.4M | Buy |
|
|||||
|
2016
Q2 | $6.76M | Buy |
|